A Clinical Study to Assess the Effects of JoyRise Recovery Powder on Mitigating Alcohol Aftereffects.

Joyrise

Status: Completed

Conditions: Cognitive Impairment; Alcohol Aftereffects; Anxiety

Treatments: Dietary Supplement: JoyRise Recovery Powder; Dietary Supplement: Placebo

Study type: Interventional

Funder types: Industry

Identifiers

NCT06575972

20374

Details and patient eligibility

About

This study assesses the effectiveness of JoyRise Recovery Powder in reducing alcohol aftereffects, cognitive impairment, and anxiousness among participants aged 35-54 who consume alcohol. Participants will be randomly assigned to either the JoyRise group or a placebo group. The study will measure hangover symptoms, cognitive function, and overall well-being through a series of questionnaires and cognitive tests at baseline, 30 minutes after product consumption, and 4 hours later.

Enrollment: 60 patients

Sex: All

Ages: 35 to 54 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Aged 35-54, male or female
• Regular alcohol consumption
• Event planned within one month that involves alcohol consumption
• Willingness to avoid new medications or supplements during the study period
• Must confirm that they will not drive while under the influence of alcohol.

Exclusion criteria

• Anyone not in good health.
• Anyone who has any chronic health conditions such as oncological or psychiatric disorders.
• Anyone who has any known serious allergic reactions that require the use of an Epi-Pen.
• Anyone who is pregnant, breastfeeding, or trying to conceive.
• Anyone who cannot/ will not commit to the study protocol.
• Anyone with a history of substance abuse.
• Anyone who has undergone an invasive medical procedure in the six months prior to the study, or has a procedure planned during the study duration.
• Anyone currently using any medications that may affect their response to alcohol or impact hangover symptoms, such as diuretics (water pills) or medication for hypertension.
• History of severe reactions or sensitivity to alcohol.
• Anyone currently taking glutathione.

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind

---

60 participants in 2 patient groups, including a placebo group

JoyRise Recovery Powder

Experimental group

Description:

Participants in this arm will receive JoyRise Recovery Powder, a dietary supplement containing Dihydromyricetin (DHM) and other natural ingredients.

Treatment:

Dietary Supplement: JoyRise Recovery Powder

Placebo

Placebo Comparator group

Description:

Participants in this arm will receive a placebo solution that is visually and tastefully similar to the JoyRise Recovery Powder but contains no active ingredients.

Treatment:

Dietary Supplement: Placebo